- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03829072
Cooking Education and Adapted Physical Activity in Allografted Patients (NUTRITION)
Impact of Cooking Education and Adapted Physical Activity on Nutritional Status and Quality of Life of Patients Treated by Allo Stem Cell Transplantation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Bone marrow transplantation is the main strategy to cure leukemia and others hematopoietic malignancies. It includes a first step of chemotherapy during several days (combined sometimes to radiotherapy), a second step of stem cells infusion and a third step of management of complications during several months: side effects, infections or graft versus host disease (GvHD). Symptoms are cutaneous, hepatic and digestive (nausea, diarrhea, vomiting) and could be unfortunately followed by the death of the patients.
Nutritional status is known to be important during the treatment of all cancers. After bone marrow transplantation, patients could have some digestive disorders that could induce malnutrition that could have an impact of time of hospitalization, intensity of complications and outcome of these ones.
When patients go back home after allo stem cell transplantation, they take several medicines, they have digestive side effects of past treatments could alter mucous, taste and all digestive tracts. During at least 100 days, patients take immunosuppressive therapies and they are going to develop new immune system. Therefore, they must follow some food rules to avoid infectious diseases. Patients feel some difficulties to eat good food and refuse often social activities. All of these have an impact on quality of life and induce an increase of malnutrition observed already directly after allo stem cell transplantation. Some complications could also increase malnutrition like digestive GvHD or digestive infections. Malnutrition could also induce physical troubles. Patients need until one year to recover physical conditions before the disease.
The aims of the study are to improve nutritional status and physical activity of patients after allo stem cell transplantation.
The investigators propose at all patients included in the study cooking education and adapted physical activity every twice week in alternance. Cooking education will be performed by two famous chefs in their kitchens. Patients (until 3 months after bone marrow transplantation) and one member of their family are invited to cook and taste. They will receive lot of advice to make several recipes at home and will adapt their cooking methods to respect food rules. Adapted physical activity will be performed by a sportive coach at home. The coach will give them some physical exercises to do between two sessions.
Patients, aged more than 18 years old and signing the consent form, are included in the study before allo stem cell transplantation. Nutritional status evaluation will be performed by a nutritionist using some tests: sit up test, hand grip, bioelectrical impedance analysis, mid upper arm circumference, analogic evaluation of appetite, blood tests: C reactive protein, transthyretin, albumin. The nutritionist will analyze also body mass index, the weight loss percent, the subjective global assessment, the health quality of life assessment.
Evaluation will be performed before allo stem cell transplantation, at day 0, 30, 100 and 300.
The aims of the study are to observe an improvement of nutritional status, quality of life, a decrease of the number of infections and GvHD and at the end an increase of overall survival.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nice, France, 06200
- CHU de Nice - Hôpital de l'Archet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient at least 18 years old
- Having been an allograft of CSH
- Patient having read and understood the information note related to the study, and signed the informed consent form.
Exclusion Criteria:
- Patient requiring nutritional support by enteral or parenteral route at J30
- Follow-up of the patient considered difficult by the investigator.
- Patient with a linguistic or psychic disability to understand the information.
- Vulnerable patient under legal protection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: cooking Education and adapted physical activity
|
cooking Education and adapted physical activity on patients after allo stem cell transplantation
cooking Education and adapted physical activity on patients after allo stem cell transplantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body mass index
Time Frame: at pre transplant
|
Body mass index
|
at pre transplant
|
|
Body mass index
Time Frame: at Day 0
|
Body mass index
|
at Day 0
|
|
Body mass index
Time Frame: at Day 30
|
Body mass index
|
at Day 30
|
|
Body mass index
Time Frame: at Day 100
|
Body mass index
|
at Day 100
|
|
Body mass index
Time Frame: at Day 300
|
Body mass index
|
at Day 300
|
|
visual analogic scale of appetite
Time Frame: at pre transplant
|
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption.
Score from 1 to 10.
There are not better or worse values.
|
at pre transplant
|
|
visual analogic scale of appetite
Time Frame: at Day 0
|
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption.
Score from 1 to 10.
There are not better or worse values
|
at Day 0
|
|
visual analogic scale of appetite
Time Frame: at Day 30
|
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption.
Score from 1 to 10.
There are not better or worse values
|
at Day 30
|
|
visual analogic scale of appetite
Time Frame: at Day 100
|
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption.
Score from 1 to 10.
There are not better or worse values
|
at Day 100
|
|
visual analogic scale of appetite
Time Frame: at Day 300
|
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption.
Score from 1 to 10.
There are not better or worse values
|
at Day 300
|
|
sit up test
Time Frame: at pre transplant
|
sit up test
|
at pre transplant
|
|
sit up test
Time Frame: at Day 0
|
sit up test
|
at Day 0
|
|
sit up test
Time Frame: at Day 30
|
sit up test
|
at Day 30
|
|
sit up test
Time Frame: at Day 100
|
sit up test
|
at Day 100
|
|
sit up test
Time Frame: at Day 300
|
sit up test
|
at Day 300
|
|
bio electrical impedance analysis,
Time Frame: at pre transplant
|
it's measuring the resistance of biological tissues
|
at pre transplant
|
|
bio electrical impedance analysis,
Time Frame: at Day 0
|
it's measuring the resistance of biological tissues
|
at Day 0
|
|
bio electrical impedance analysis,
Time Frame: at Day 30
|
it's measuring the resistance of biological tissues
|
at Day 30
|
|
bio electrical impedance analysis,
Time Frame: at Day 100
|
it's measuring the resistance of biological tissues
|
at Day 100
|
|
bio electrical impedance analysis,
Time Frame: at Day 300
|
it's measuring the resistance of biological tissues
|
at Day 300
|
|
hand grip
Time Frame: at pre transplant
|
hand grip
|
at pre transplant
|
|
hand grip
Time Frame: at Day 0
|
hand grip
|
at Day 0
|
|
hand grip
Time Frame: at Day 30
|
hand grip
|
at Day 30
|
|
hand grip
Time Frame: at Day 100
|
hand grip
|
at Day 100
|
|
hand grip
Time Frame: at Day 300
|
hand grip
|
at Day 300
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life assessment,
Time Frame: at pre transplant
|
it's a satisfaction patient's scale
|
at pre transplant
|
|
Quality of life assessment,
Time Frame: at Day 0
|
it's a satisfaction patient's scale
|
at Day 0
|
|
Quality of life assessment,
Time Frame: at Day 30
|
it's a satisfaction patient's scale
|
at Day 30
|
|
Quality of life assessment,
Time Frame: at Day 100
|
it's a satisfaction patient's scale
|
at Day 100
|
|
Quality of life assessment,
Time Frame: at Day 300
|
it's a satisfaction patient's scale
|
at Day 300
|
|
number of infections,
Time Frame: at pre transplant
|
number of infections,
|
at pre transplant
|
|
number of infections,
Time Frame: at Day 0
|
number of infections,
|
at Day 0
|
|
number of infections,
Time Frame: at Day 30
|
number of infections,
|
at Day 30
|
|
number of infections,
Time Frame: at Day 100
|
number of infections,
|
at Day 100
|
|
number of infections,
Time Frame: at Day 300
|
number of infections,
|
at Day 300
|
|
number of graft versus host disease,
Time Frame: at pre transplant
|
number of graft versus host disease,
|
at pre transplant
|
|
number of graft versus host disease,
Time Frame: at Day 0
|
number of graft versus host disease,
|
at Day 0
|
|
number of graft versus host disease,
Time Frame: at Day 30
|
number of graft versus host disease,
|
at Day 30
|
|
number of graft versus host disease,
Time Frame: at Day 100
|
number of graft versus host disease,
|
at Day 100
|
|
number of graft versus host disease,
Time Frame: at Day 300
|
number of graft versus host disease,
|
at Day 300
|
|
overall survival
Time Frame: at pre transplant
|
overall survival
|
at pre transplant
|
|
overall survival
Time Frame: at Day 0
|
overall survival
|
at Day 0
|
|
overall survival
Time Frame: at Day 30
|
overall survival
|
at Day 30
|
|
overall survival
Time Frame: at Day 100
|
overall survival
|
at Day 100
|
|
overall survival
Time Frame: at Day 300
|
overall survival
|
at Day 300
|
Collaborators and Investigators
Investigators
- Principal Investigator: Thomas Cluzeau, Centre Hospitalier Universitaire de Nice
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 18-PP-10
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Allograft
-
Tongji HospitalNational Natural Science Foundation of ChinaRecruitingKidney Transplant | Renal Allograft Recipients | Renal AllograftChina
-
University Hospital, LimogesRecruiting
-
Kafrelsheikh UniversityNot yet recruiting
-
University Hospital, LimogesCompleted
-
University of CincinnatiCompletedPrimary Renal AllograftUnited States
-
Andrew B AdamsBristol-Myers SquibbCompletedFailing Renal AllograftUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedRenal Allograft Recipients
-
Tanta UniversityEnrolling by invitationMaxillary Sinus Augmentation Using CAD/CAM Allogenic Bone Blocks Versus Particulate Allogenic GraftsMaxillary Sinus | AllograftEgypt
-
Chelyabinsk Regional Clinical HospitalCompleted
-
Arab American University (Palestine)CompletedA-PRF | ALLOGRAFTPalestinian Territory, occupied
Clinical Trials on Cooking Education
-
Fundacion para la Investigacion Biomedica del Hospital...Withdrawn
-
The Cleveland ClinicThe Honor Project TrustCompleted
-
Cornell UniversityUnited States Department of Agriculture (USDA)Completed
-
The Cleveland ClinicCity of Warrensville Heights; Ohio Department of AgingCompleted
-
Boston Children's HospitalThrasher Research FundTerminated
-
Johns Hopkins UniversityCompleted
-
The Miriam HospitalCompleted
-
Colorado State UniversityUniversity of Colorado, Denver; United States Department of Agriculture (USDA) and other collaboratorsRecruitingType 2 Diabetes | Obesity, Adolescent | Mental Health | Adolescent Health | Lifestyle Risk Reduction | Family Health | Wellness Program | Cardio-metabolic HealthUnited States
-
University of VermontCompleted